Abstract
AT most synapses, chemical signalling is terminated by a rapid reaccumulation of neurotransmitter into presynaptic terminals1–5. Uptake systems for the biogenic amines are the initial site of action for therapeutic antidepressants and drugs such as cocaine and the amphetamines. We have isolated a complementary DNA clone encoding a human noradrenaline transporter. The cDNA sequence predicts a protein of 617 amino acids, with 12–13 highly hydrophobic regions compatible with membrane-spanning domains. Expression of the cDNA clone in transfected HeLa cells indicates that noradrenaline transport activity is sodium-dependent and sensitive to selective noradrenaline transport inhibitors. Trans-porter RNA is localized to the brainstem and the adrenal gland. The predicted protein sequence demonstrates significant amino-acid identity with the Na+/γ-aminobutyric acid transporter, thus identifying a new gene family for neurotransmitter transporter proteins. Analysis of its structure and function may lead to structure-based drug design for the treatment of human depression and could help determine whether transporter abnormalities underlie affective disorders.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Snyder, S. H. Biol. Psychiat. 2, 367–389 (1970).
Iversen, L. L. The Uptake and Storage of Noradrenaline in Sympathetic Nerves (Cambridge University Press, New York, 1967).
Horn, A. S. Prog. Neurobio. 34, 387–400 (1990).
Kuhar, M. J. et al. Eur. Neurol. 30 (suppl. 1) 15–20 (1990).
Kanner, B. I. & Schuldiner, S. CRC crit. Rev. Biochem. 22, 1–38 (1987).
D'Andrea, A. D., Lodish, H. F. & Wong, G. G. Cell 57, 277–285 (1989).
Sims, J. E. et al. Science 241, 585–589 (1988).
Munro, S. & Maniatis, T. Proc. natn. Acad. Sci. U.S.A. 86, 9248–9252 (1989).
Biedler, J. L., Helson, L. & Spengler, B. A. Cancer Res. 33, 2643–2652 (1973).
Buck, J., Bruchelt, G., Girgert, R., Treuner, J. & Niethammer, D. Cancer Res. 45, 6366–6370 (1985).
Smets, L. A., Loesberg, C., Janssen, M., Metwally, E. A. & Huiskamp, R. Cancer Res. 49, 2941–2944 (1989).
Richards, M. L. & Sadee, W. Brain Res. 384, 132–137 (1986).
Hirt, B. J. molec. Biol. 26, 365–369 (1967).
Kozak, M. Nucleic Acids Res. 15, 8125–8148 (1987).
Kyte, J. & Doolittle, R. F. J. molec. Biol. 157, 105–132 (1982).
von Heijne, G. Eur. J. Biochem. 133, 17–21 (1983).
Guastella, J. et al. Science 249, 1303–1306 (1990).
Nelson, H., Mandiyan, S. & Nelson, N. FEBS Lett. 269, 181–184 (1990).
Greene, L. A. & Rein, G. Brain Res. 129, 247–263 (1977).
Kimelberg, H. K. & Pelton, II E. W. J. Neurochem. 40, 1265–1270 (1983).
Richelson, E. & Pfenning, M. Eur. J. Pharmac. 104, 277–286 (1984).
Javitch, J. A., Blaustein, R. O. & Snyder, S. H. Molec. Pharmacol. 26, 35–44 (1984).
Andersen, P. H. Eur. J. Pharmac. 166, 493–504 (1989).
Ritz, M. C., Lamb, R. J., Goldberg, S. R. & Kuhar, M. J. Science 237, 1219–1223 (1987).
Cho, A. K. Science 249, 631–634 (1990).
Javitch, J. A., D'Amato, R. J., Strittmatter, S. M. & Snyder, S. H. Proc. natn. Acad. Sci. U.S.A. 82, 2173–2177 (1985).
Ross, S. B. & Renyi, A. L. J. Pharm. Pharmac. 28, 458–459 (1976).
Kostrzewa, R. M. & Jacobowitz, D. M. Pharmac. Rev. 26, 199–288 (1974).
Schildkraut, J. J. Am. J. Psychiatr. 122, 509–522 (1965).
Cheng, Y. & Prusoff, W. H. Biochem. Pharmac. 22, 3099–3108 (1973).
White, M. K. & Weber, M. J. Nature 340, 103–104 (1989).
Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J. & Rutter, W. J. Biochemistry 18, 5294–5299 (1979).
Lopata, M. A., Cleveland, D. W. & Sollner-Webb, B. Nucleic Acids Res. 12, 5707–5717 (1984).
Luthman, H. & Magnusson, G. Nucleic Acids Res. 11, 1295–1308 (1983).
Sanger, F., Nicklen, S. & Coulson, A. R. Proc. natn. Acad. Sci. U.S.A. 74, 5463–5467 (1977).
Fuerst, T. R., Niles, E. G., Studier, F. W. & Moss, B. Proc. natn. Acad. Sci. U.S.A. 83, 8122–8126 (1986).
Blakely, R. D., Clark, J. A., Rudnick, G. & Amara, S. G. Analyt. Biochem. 194, 302–308 (1991).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pacholczyk, T., Blakely, R. & Amara, S. Expression cloning of a cocaine-and antidepressant-sensitive human noradrenaline transporter. Nature 350, 350–354 (1991). https://doi.org/10.1038/350350a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/350350a0
This article is cited by
-
The monoaminergic system is a bilaterian innovation
Nature Communications (2023)
-
Reconstitution of GABA, Glycine and Glutamate Transporters
Neurochemical Research (2022)
-
Serotonin Transporter Ala276 Mouse: Novel Model to Assess the Neurochemical and Behavioral Impact of Thr276 Phosphorylation In Vivo
Neurochemical Research (2022)
-
Forty Four Years With Baruch Kanner and The Chloride Ion
Neurochemical Research (2022)
-
Phosphatidylinositol 4,5-bisphosphate (PIP2) facilitates norepinephrine transporter dimerization and modulates substrate efflux
Communications Biology (2022)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.